Identifying meaningful symptoms and impacts of disease for patients with early Parkinson’s disease
Objective: To explore meaningful symptoms and impacts of disease on daily living in individuals with early-stage Parkinson’s disease (PD). Background: Critical Path for Parkinson’s (CPP)…Gut dysbiosis in patients with dementia with Lewy bodies
Objective: To identify intestinal bacteria that are changed in DLB alone or in both DLB and cognitive decline in Parkinson’s disease (PD). Background: Gut microbiota…Cortical oscillatory feature-based classification of Parkinson’s disease with freezing gait
Objective: The objective of this study was to determine the resting-state cortical oscillations and the machine learning model that best classifies Parkinson’s disease (PD) patients…Telemedicine in a Himalayan country: unlocking the barrier in the management of Parkinson’s Disease
Objective: To evaluate the feasibility of telemedicine among PD patients in Nepal. Background: Nepal is a mountainous country occupying about 85% by Himalayas and hills…Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression
Objective: To investigate thalamic subnuclei volume and macrostructural white matter changes in Parkinson’s disease (PD) depression. Background: Depression is a common neuropsychiatric feature of Parkinson’s…Assessment of non-motor symptoms of Parkinson’s disease in the long-term follow-up after the cell therapy
Objective: To evaluate the results of the introduction of MSCs on the non-motor symptoms in patients with PD within 12 months after the cell therapy.…Characterising Natural Killer cells in early Parkinson’s disease
Objective: To determine whether the number and phenotype of Natural Killer (NK) cells in the blood is altered in early Parkinson’s disease (PD). Background: Accumulating…Intermediate cardiac denervation in early Parkinson’s disease
Objective: This study is aimed to evaluate the longitudinal associations between cardiac sympathetic denervation and cognitive status in Parkinson’s disease (PD). Background: There lacks an…Multi-modal prognostic biomarkers for Parkinson’s disease progression and severity
Objective: To determine a pathophysiological panel of biomarkers significantly associated with the severity and the disease progression of Parkinson’s disease. Background: Detecting, monitoring and predicting…The USP Project: Understanding the Scope and Value of Parkinson’s Specialist Nursing
Objective: This paper will present evidence from the first stakeholder-driven UK study to explore in-depth the role and value of the Parkinson’s Nurse Specialist (PNS)…
- « Previous Page
- 1
- …
- 206
- 207
- 208
- 209
- 210
- …
- 338
- Next Page »